Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery

Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma

(2010) M A Gertz et al.   BONE MARROW TRANSPLANTATION

Treatment with Plerixafor in non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF: Implications for the Heavily Pretreated Patient

(2009) Patrick Stiff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

(2009) Douglas A. Stewart et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation

(2009) Patrick Wuchter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

(2009) S Giralt et al.   LEUKEMIA

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

(2008) Iskra Pusic et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Managing relapsed and refractory Hodgkin lymphoma

(2008) Pauline Brice   BRITISH JOURNAL OF HAEMATOLOGY

ABO type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients

(2008)   TRANSFUSION